09:19 AM EST - Custom Health Holdings Inc. : Announced its consolidated financial results for the fiscal first quarter ended March 31, 2026. For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million. Custom Health Holdings Inc.
shares T.CHLT are trading unchanged at $8.00.
